Literature DB >> 27676368

Inhibition of Low Molecular Weight Protein Tyrosine Phosphatase by an Induced-Fit Mechanism.

Rongjun He1, Jifeng Wang1, Zhi-Hong Yu1, Ruo-Yu Zhang1, Sijiu Liu1, Li Wu1, Zhong-Yin Zhang1.   

Abstract

The low molecular weight protein tyrosine phosphatase (LMW-PTP) is a regulator of a number of signaling pathways and has been implicated as a potential target for oncology and diabetes/obesity. There is significant therapeutic interest in developing potent and selective inhibitors to control LMW-PTP activity. We report the discovery of a novel class of LMW-PTP inhibitors derived from sulfophenyl acetic amide (SPAA), some of which exhibit greater than 50-fold preference for LMW-PTP over a large panel of PTPs. X-ray crystallography reveals that binding of SPAA-based inhibitors induces a striking conformational change in the LMW-PTP active site, leading to the formation of a previously undisclosed hydrophobic pocket to accommodate the α-phenyl ring in the ligand. This induced-fit mechanism is likely a major contributor responsible for the exquisite inhibitor selectivity.

Entities:  

Year:  2016        PMID: 27676368      PMCID: PMC6348062          DOI: 10.1021/acs.jmedchem.6b00993

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

Review 1.  Protein tyrosine phosphatases (PTPs) in diabetes: causes and therapeutic opportunities.

Authors:  Chiranjeev Sharma; Youllee Kim; Dohee Ahn; Sang J Chung
Journal:  Arch Pharm Res       Date:  2021-02-15       Impact factor: 4.946

Review 2.  Targeting Tyrosine Phosphatases: Time to End the Stigma.

Authors:  Stephanie M Stanford; Nunzio Bottini
Journal:  Trends Pharmacol Sci       Date:  2017-04-12       Impact factor: 14.819

Review 3.  Functional interrogation and therapeutic targeting of protein tyrosine phosphatases.

Authors:  Aaron D Krabill; Zhong-Yin Zhang
Journal:  Biochem Soc Trans       Date:  2021-08-27       Impact factor: 5.407

Review 4.  Low molecular weight protein tyrosine phosphatase as signaling hub of cancer hallmarks.

Authors:  Alessandra V S Faria; Emanuella Maria Barreto Fonseca; Helon Guimarães Cordeiro; Stefano Piatto Clerici; Carmen Veríssima Ferreira-Halder
Journal:  Cell Mol Life Sci       Date:  2020-10-14       Impact factor: 9.261

5.  Computational Strategy for Bound State Structure Prediction in Structure-Based Virtual Screening: A Case Study of Protein Tyrosine Phosphatase Receptor Type O Inhibitors.

Authors:  Xuben Hou; David Rooklin; Duxiao Yang; Xiao Liang; Kangshuai Li; Jianing Lu; Cheng Wang; Peng Xiao; Yingkai Zhang; Jin-Peng Sun; Hao Fang
Journal:  J Chem Inf Model       Date:  2018-10-19       Impact factor: 4.956

Review 6.  Protein tyrosine phosphatases in cardiac physiology and pathophysiology.

Authors:  Fallou Wade; Karim Belhaj; Coralie Poizat
Journal:  Heart Fail Rev       Date:  2018-03       Impact factor: 4.214

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.